Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g Vct5 Regulatory News (MIG5)

Share Price Information for Maven I&g Vct5 (MIG5)

Share Price is delayed by 15 minutes
Get Live Data
28.00    0.00 (0.00%)
Bid:
27.00
Ask:
29.00
Spread: 2.00 (7.407%)
Market Cap: £73.24m
MIG5 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g Vct5 Share Chart

Statement re Offer for Subscription

28 Jan 2021 16:40

RNS Number : 2708N
Maven Income & Growth VCT PLC
28 January 2021
 

Maven Income and Growth VCT PLC and Maven Income and Growth VCT 5 PLC (the Companies)

 

Offers for Subscription

 

28 January 2021

 

On 23 October 2020, the Companies announced the publication of a joint Prospectus (comprising a Securities Note, Registration Document and Summary) in relation to offers for subscription of new Ordinary Shares of 10p each (together the "Offers" and each an "Offer").

 

In the Prospectus, it was stated that all valid Applications that were received (together with their relevant application monies) and accepted by the deadline of 12.00 noon on 29 January 2021 would be eligible to receive an Early Investment Incentive discount under the Offers. Existing Shareholders (and their spouses or partners) in any of the Maven VCTs, including the Companies, at the time the Application was received would benefit from an enhanced rate of discount in recognition of their continued support for the Maven VCTs. The levels of discount to be applied would be:

 

· 1.5% of the Application Amount for Existing Shareholders; and

· 1.25% of the Application Amount for New Investors.

 

It was also stated that each Company could, in consultation with Maven Capital Partners UK LLP (Maven) and in their absolute discretion, extend the deadline by which Applications must be received and accepted to be eligible for the Early Investment Incentive under its Offer.

 

The Board of each Company confirms that the deadline by which Applications must be received and accepted to be eligible for the Early Investment Incentive under their Company's respective Offer has been extended until 12.00 noon on Friday 26 February 2021. Furthermore, it is anticipated that both Companies will make initial allotments of new Ordinary Shares under their respective Offers as soon as practicable after that date.

 

Further information

 

Any enquiries in respect of the Offers, or requests for copies of the Prospectus documents (available free of charge), should be directed to:

 

Maven Capital Partners UK LLP

Kintyre House

205 West George Street

Glasgow

G2 2LW

 

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Downloadable versions of the Prospectus documents are available from the Maven website at: www.mavencp.com/vctoffer.

Maven Capital Partners UK LLPSecretary

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRQVLFLFFLXBBK
Date   Source Headline
22nd Apr 20143:00 pmRNSResult of AGM
22nd Apr 20142:58 pmRNSDirectorate Change
17th Apr 20143:57 pmRNSInterim Management Statement
16th Apr 201411:49 amRNSDirector Declaration
7th Apr 20144:19 pmRNSOffer for Subscription - Supplementary Prospectus
7th Apr 201411:32 amRNSIssue of Equity
18th Mar 20147:00 amRNSOffer for Subscription - Supplementary Prospectus
3rd Mar 20144:13 pmRNSAnnual Financial Report
13th Feb 201410:57 amRNSDirector/PDMR Shareholding
13th Feb 201410:55 amRNSDirector/PDMR Shareholding
13th Feb 201410:47 amRNSDirector/PDMR Shareholding
10th Feb 20146:04 pmRNSOffer for Subscription - Supplementary Prospectus
5th Feb 20144:22 pmRNSIssue of Equity
3rd Feb 20145:23 pmRNSStatement re NAV and Offer for Subscription (Repla
27th Jan 20145:00 pmRNSStatement re NAV, Dividend and Offer
27th Nov 20132:07 pmRNSResult of General Meeting
24th Oct 20136:09 pmRNSOffer for Subscription
15th Oct 20135:10 pmRNSTransaction in Own Shares
11th Oct 20135:12 pmRNSInterim Management Statement
11th Oct 201312:18 pmRNSDirectorate Change
10th Oct 201311:02 amRNSNet Asset Value(s)
9th Oct 201311:09 amRNSNet Asset Value(s)
8th Oct 20131:49 pmRNSNet Asset Value(s)
7th Oct 201312:35 pmRNSNet Asset Value(s)
4th Oct 20132:12 pmRNSNet Asset Value(s)
3rd Oct 20132:36 pmRNSNet Asset Value(s)
2nd Oct 201312:21 pmRNSNet Asset Value(s)
1st Oct 201312:27 pmRNSNet Asset Value(s)
30th Sep 20132:43 pmRNSNet Asset Value(s)
27th Sep 201312:04 pmRNSNet Asset Value(s)
26th Sep 201311:57 amRNSNet Asset Value(s)
25th Sep 201312:22 pmRNSNet Asset Value(s)
25th Sep 201311:39 amRNSStatement re Proposed Joint Fund Raising
24th Sep 201311:52 amRNSNet Asset Value(s)
23rd Sep 201311:47 amRNSNet Asset Value(s)
20th Sep 20132:15 pmRNSNet Asset Value(s)
19th Sep 20131:05 pmRNSNet Asset Value(s)
18th Sep 201310:16 amRNSNet Asset Value(s)
17th Sep 201310:38 amRNSNet Asset Value(s)
16th Sep 201311:35 amRNSNet Asset Value(s)
13th Sep 201311:25 amRNSNet Asset Value(s)
12th Sep 201311:09 amRNSNet Asset Value(s)
11th Sep 201312:26 pmRNSNet Asset Value(s)
10th Sep 201312:22 pmRNSNet Asset Value(s)
9th Sep 20131:41 pmRNSNet Asset Value(s)
6th Sep 201311:44 amRNSNet Asset Value(s)
5th Sep 20131:14 pmRNSDirector Declaration
5th Sep 201312:33 pmRNSNet Asset Value(s)
4th Sep 20131:37 pmRNSNet Asset Value(s)
3rd Sep 201310:50 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.